Abstract
AKR/J mice, 80-90% of which ordinarily die of spontaneous lymphocytic leukemias by 12 months of age, were significantly protected from developing leukemia in the initial experiment by a single course of treatment with AKR serotype-specific antibodies mad in goats and processed as immune gamma globulin (IgG). In experiment 1, IgG was given on the day of birth and on four additional days, and finished on day 14. This schedule resulted in suppression of over 4 logarithms of normal virogene expressions up to 25 days of age and led to partial viral suppression for over 200 days of age. At 365 days of age, 20 of 24 (83.3%) control animals were dead of leukemia whereas six of 30 (20%) treated animals had died of leukemia. In a second experiment, only four inoculations of IgG were given from birth to 20 days, after which they were given three inoculations of radiation-killed vaccine specific for AKR-Gross leukemia virus and one injection of murine sarcoma virus-Gross leukemia virus 10 days later. This combined immunization procedure provided significant virus suppression up to 288 days of age. At 300 days of age, 30 of the 50 (60%) controls had died of leukemia while only 1 of 24 (4.2%) of the immunized mice developed fatal leukemia; the significance of protection for each of the experiments was P LESS THAN 0.001. We conclude that these data establish in classical fashion with type-specific immunosuppression the determining role of type-C endogenous virogenes in leukemogenesis and, at the same time, also established the feasibility of nearly total prevention of leukemia in AKR mice.
Full text
PDF


Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Aoki T., Boyse E. A., Old L. J. Wild-type Gross leukemia virus. II. Influence of immunogenetic factors on natural transmission and on the consequences of infection. J Natl Cancer Inst. 1968 Jul;41(1):97–101. [PubMed] [Google Scholar]
- Berns A., Jaenisch R. Increase of AKR-specific sequences in tumor tissues of leukemic AKR mice. Proc Natl Acad Sci U S A. 1976 Jul;73(7):2448–2452. doi: 10.1073/pnas.73.7.2448. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Chattopadhyay S. K., Rowe W. P., Teich N. M., Lowy D. R. Definitive evidence that the murine C-type virus inducing locus Akv-1 is viral genetic material. Proc Natl Acad Sci U S A. 1975 Mar;72(3):906–910. doi: 10.1073/pnas.72.3.906. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Hartley J. W., Rowe W. P. Clonal cells lines from a feral mouse embryo which lack host-range restrictions for murine leukemia viruses. Virology. 1975 May;65(1):128–134. doi: 10.1016/0042-6822(75)90013-6. [DOI] [PubMed] [Google Scholar]
- Heiniger H. J., Meier H., Kaliss N., Cherry M., Chen H. W., Stoner R. D. Hereditary immunodeficiency and leukemogenesis in HRS-J mice. Cancer Res. 1974 Jan;34(1):201–211. [PubMed] [Google Scholar]
- Hibbs J. B., Jr, Lambert L. H., Jr, Remington J. S. Adjuvant induced resistance to tumor development in mice. Proc Soc Exp Biol Med. 1972 Mar;139(3):1053–1056. doi: 10.3181/00379727-139-36296. [DOI] [PubMed] [Google Scholar]
- Huebner R. J., Gilden R. V., Lane W. T., Toni R., Trimmer R. W., Hill P. R. Suppression of murine type-C RNA virogenes by type-specific oncornavirus vaccines: prospects for prevention of cancer. Proc Natl Acad Sci U S A. 1976 Feb;73(2):620–624. doi: 10.1073/pnas.73.2.620. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Huebner R. J., Todaro G. J. Oncogenes of RNA tumor viruses as determinants of cancer. Proc Natl Acad Sci U S A. 1969 Nov;64(3):1087–1094. doi: 10.1073/pnas.64.3.1087. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LAW L. W., MILLER J. H. Observations on the effect of thymectomy on spontaneous leukemias in mice of the highleukemic strains, RIL and C 58. J Natl Cancer Inst. 1950 Oct;11(2):253–262. [PubMed] [Google Scholar]
- LIEBERMAN M., KAPLAN H. S. Leukemogenic activity of filtrates from radiation-induced lymphoid tumors of mice. Science. 1959 Aug 14;130(3372):387–388. doi: 10.1126/science.130.3372.387. [DOI] [PubMed] [Google Scholar]
- Lemonde P. Protective effects of BCG and other bacteria against neoplasia in mice and hamsters. Natl Cancer Inst Monogr. 1973 Dec;39:21–32. [PubMed] [Google Scholar]
- Lilly F., Duran-Reynals M. L., Rowe W. P. Correlation of early murine leukemia virus titer and H-2 type with spontaneous leukemia in mice of the BALB/c times AKR cross: a genetic analysis. J Exp Med. 1975 Apr 1;141(4):882–889. [PMC free article] [PubMed] [Google Scholar]
- Lunde M. N., Gelderman A. H. Resistance of AKR mice to lymphoid leukemia associated with a chronic protozoan infection, Besnoitia jellisoni. J Natl Cancer Inst. 1971 Aug;47(2):485–488. [PubMed] [Google Scholar]
- MACDOWELL E. C. Mouse leukemia. XVI. Spontaneous cases in strain C58 resisted by milk of old STOLI foster nurses. Cancer Res. 1955 Jan;15(1):23–25. [PubMed] [Google Scholar]
- Meier H., Taylor B. A., Cherry M., Buebner R. J. Host-gene control of type-C RNA tumor virus expression and tumorigenesis in inbred mice. Proc Natl Acad Sci U S A. 1973 May;70(5):1450–1455. doi: 10.1073/pnas.70.5.1450. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Price P. J., Bellew T. M., King M. P., Freeman A. E., Gilden R. V., Huebner R. J. Prevention of viral-chemical co-carcinogenesis in vitro by type-specific anti-viral antibody. Proc Natl Acad Sci U S A. 1976 Jan;73(1):152–155. doi: 10.1073/pnas.73.1.152. [DOI] [PMC free article] [PubMed] [Google Scholar]